Navigation Links
Seniors Can Be Heartened by New Study on Statins
Date:11/13/2008

Groundbreaking Research Finds Statins Cut Risk of Heart Attacks, Deaths

RESTON, Va., Nov. 13 /PRNewswire-USNewswire/ -- Cardiovascular Disease is the leading cause of death among Americans, costing our healthcare system hundreds of millions of dollars and causing untold suffering. Now there is new hope for preventing this fatal disease - even among those who weren't thought to be at risk.

A new study has found that millions of people could cut their risk of a heart attack, stroke and death by taking statins. The study, released at the American Medical Association's annual meeting this week, found the benefits even for people with low cholesterol and no major risk for heart disease.

"This is the kind of news that could really save lives," said Michelle Plasari, President of RetireSafe's Senior Center for Health and Security. "According to this study, even people who believe they are at low risk for a heart attack could benefit from taking statins. This could transform the way we prevent heart disease."

About half all heart attacks and strokes occur in people who do not have elevated cholesterol. This study showed that a daily dose of a statin called rosuvastatin can prevent heart attacks and deaths in that group - people who would not normally be treated for heart disease.

Patients in the study had normal cholesterol. But they had higher levels of C-reactive protein, a marker of inflammation that indicates a risk of heart disease.

"This study shows that even if you have low cholesterol levels, you aren't safe from heart disease," Plasari said.

According to the American Heart Association, Americans over the age of 65 are at the highest risk of developing heart disease. At this age, initial heart attacks tend to be more fatal than those suffered at a younger age.

The first step to protecting yourself from heart disease is maintaining a healthy lifestyle. This can include a balanced diet, weight loss, exercise, smoking cessation, and limiting the amount of alcohol consumed.

"This study shows statins could be one more way to protect yourself from heart disease," Plasari said.

Statins are a class of prescription drugs that lower the level of cholesterol in the blood by reducing the production of cholesterol by the liver. Combined with diet and exercise, statins are estimated to lower blood cholesterol levels by as much as 40 to 60 percent.

Statins have not only been clinically-proven to lower cholesterol and reduce the risk of heart disease, they have been linked to lowering the risk of dying from emphysema, chronic bronchitis, influenza, and pneumonia.

To learn more about atherosclerosis and heart disease, visit http://seniorsforcures.org/sfc-newsletter-march-2008.pdf .


'/>"/>
SOURCE RetireSafe
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. More Than 1.5 Million Americans Sickened, Injured or Killed by Medication Errors Each Year; Seniors Most at Risk
2. Soft Contact Lenses Do Not Lead to Myopic Creep in Children, Study Shows
3. Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
4. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
5. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
6. Physicians Health Study II Finds No Magic Bullet for Preventing Cardiovascular Disease
7. Study Showed Prevention of Heart Attacks Within Three Months After Hospitalization Significantly Averted Future Heart Attacks and Death
8. CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study
9. Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids
10. Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
11. Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... human induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces ... Medium. The PluriQ™ G9™ Gene Editing System is a complete system ...
Breaking Medicine News(10 mins):